BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22410201)

  • 41. [Takayasu arteritis of atypical presentation. Tocilizumab as an alternative therapeutic option].
    Cubiles Arillo Z; Núñez Cuadros E; Martínez Rivera V; González Gómez JM; Cuenca Peiró V
    An Pediatr (Engl Ed); 2019 Dec; 91(6):411-413. PubMed ID: 30777717
    [No Abstract]   [Full Text] [Related]  

  • 42. Ocular involvement in Takayasu's arteritis: response to cyclophosphamide therapy.
    Rodríguez-Hurtado FJ; Sabio JM; Lucena J; Jiménez-Alonso J
    Eur J Med Res; 2002 Mar; 7(3):128-30. PubMed ID: 11953284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term immunosuppressive treatment of a child with Takayasu's arteritis and high IgE immunoglobulins.
    Brunette MG; Bonny Y; Spigelblatt L; Barrette G
    Pediatr Nephrol; 1996 Feb; 10(1):67-9. PubMed ID: 8611360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
    Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
    Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
    [No Abstract]   [Full Text] [Related]  

  • 45. Multiple percutaneous transluminal angioplasties and low dose pulse methotrexate for Takayasu's arteritis.
    Liang GC; Nemickas R; Madayag M
    J Rheumatol; 1989 Oct; 16(10):1370-3. PubMed ID: 2572697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
    Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies.
    Clifford A; Hoffman GS
    Curr Opin Rheumatol; 2014 Jan; 26(1):7-15. PubMed ID: 24225487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
    Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ
    J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and radiographic features mimicking pulmonary embolism as the first manifestation of Takayasu's arteritis.
    Shlomai A; Hershko AY; Gabbay E; Ben-Chetrit E
    Clin Rheumatol; 2004 Oct; 23(5):470-2. PubMed ID: 15278757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.
    Nishimoto N; Nakahara H; Yoshio-Hoshino N; Mima T
    Arthritis Rheum; 2008 Apr; 58(4):1197-200. PubMed ID: 18383395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature.
    Batu ED; Sönmez HE; Hazırolan T; Özaltın F; Bilginer Y; Özen S
    Semin Arthritis Rheum; 2017 Feb; 46(4):529-535. PubMed ID: 27515155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Takayasu's arteritis and retroperitoneal fibrosis: a case report].
    Jghaimi F; Kabbaj A; Essaadouni L
    Rev Med Interne; 2010 Mar; 31(3):e1-3. PubMed ID: 19231040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A successful pregnancy in a patient with Takayasu's arteritis under tocilizumab treatment: A longitudinal case study.
    Dalkilic E; Coskun BN; Yağız B; Pehlivan Y
    Int J Rheum Dis; 2019 Oct; 22(10):1941-1944. PubMed ID: 31482664
    [No Abstract]   [Full Text] [Related]  

  • 54. [Large-vessel vasculitides].
    Eklund KK; Pettersson T
    Duodecim; 2011; 127(15):1539-47. PubMed ID: 21995124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Large-vessel granulomatous vasculitis during the course of sarcoidosis: Takayasu's arteritis?].
    Vaurs C; Ammoury A; Cordel N; Lamant L; Chaufour X; Paul C
    Ann Dermatol Venereol; 2009 Dec; 136(12):890-3. PubMed ID: 20004315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment with ustekinumab for corticosteroid- and immunosuppressant-resistant Takayasu's arteritis.
    Yachoui R; Kreidy M; Siorek M; Sehgal R
    Scand J Rheumatol; 2018 May; 47(3):246-247. PubMed ID: 28276951
    [No Abstract]   [Full Text] [Related]  

  • 57. [Infliximab therapy for three adolescent patients with refractory Takayasu's arteritis].
    Kaneko U; Kishi T; Kikuchi M; Hara R; Shinoki T; Miyamae T; Imagawa T; Mori M; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(6):317-23. PubMed ID: 21212584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
    Sun Y; Ma L; Chen H; Kong X; Lv P; Dai X; Ji Z; Yang C; Dai S; Wu L; Zou Y; Lin J; Shi H; Yu Q; Jiang L
    Clin Rheumatol; 2018 Oct; 37(10):2789-2795. PubMed ID: 29687289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidetector CT angiography in Takayasu arteritis.
    Khandelwal N; Kalra N; Garg MK; Kang M; Lal A; Jain S; Suri S
    Eur J Radiol; 2011 Feb; 77(2):369-74. PubMed ID: 19720487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anterior uveitis in a child with Takayasu's arteritis.
    McDonald MA; Ojaimi E; Favilla I
    Clin Exp Ophthalmol; 2004 Jun; 32(3):336-9. PubMed ID: 15180852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.